Authors:
COHEN O
ZYLBERKATZ E
CARACO Y
GRANIT L
LEVY M
Citation: O. Cohen et al., CEREBROSPINAL-FLUID AND PLASMA-CONCENTRATIONS OF DIPYRONE METABOLITESAFTER A SINGLE ORAL DOSE OF DIPYRONE, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 549-553
Citation: O. Cohen et al., PLASMA AND CEREBROSPINAL-FLUID CONCENTRATIONS OF DIPYRONE METABOLITESAFTER A SINGLE ORAL DOSE, Neurology, 50(4), 1998, pp. 1136-1136
Authors:
ZYLBERKATZ E
GOMORI MJ
SCHWARTZ A
LOSSOS A
BOKSTEIN F
SIEGAL T
Citation: E. Zylberkatz et al., VENTRICULAR CSF CONCENTRATIONS OF METHOTREXATE (MTX) AFTER HYPEROSMOLAR BLOOD-BRAIN-BARRIER DISRUPTION (HBBBD) IN PATIENTS WITH BRAIN LYMPHOMAS, Neurology, 50(4), 1998, pp. 5022-5022
Authors:
LEVY M
BRUNE K
ZYLBERKATZ E
COHEN O
CARACO Y
GEISSLINGER G
Citation: M. Levy et al., CEREBROSPINAL-FLUID PROSTAGLANDINS AFTER SYSTEMIC DIPYRONE INTAKE, Clinical pharmacology and therapeutics, 64(1), 1998, pp. 117-122
Authors:
CASPI O
ZYLBERKATZ E
GOTSMAN O
WOLF DG
CARACO Y
Citation: O. Caspi et al., DIGOXIN INTOXICATION IN A PATIENT WITH END-STAGE RENAL-DISEASE - EFFICACY OF DIGOXIN-SPECIFIC FAB ANTIBODY FRAGMENTS AND PERITONEAL-DIALYSIS, Therapeutic drug monitoring, 19(5), 1997, pp. 510-515
Authors:
COHEN G
ELAD S
ZYLBERKATZ E
OR R
FINDLER M
GALILI D
GARFUNKEL AA
Citation: G. Cohen et al., SAFETY OF TOPICAL LIDOCAINE MOUTHWASHES IN BONE-MARROW TRANSPLANTATION PATIENTS, Journal of dental research, 76, 1997, pp. 808-808
Authors:
LEVY M
LEIBOWICH I
ZYLBERKATZ E
ILAN Y
GRANIT L
SVIRI S
CARACO Y
Citation: M. Levy et al., IMPAIRMENT OF THE METABOLISM OF DIPYRONE IN ASYMPTOMATIC CARRIERS OF THE HEPATITIS-B VIRUS, Clinical pharmacology and therapeutics, 62(1), 1997, pp. 6-14
Authors:
YAZAKI T
AHMAD S
CHAHLAVI A
ZYLBERKATZ E
DEAN NM
RABKIN SD
MARTUZA RL
GLAZER RI
Citation: T. Yazaki et al., TREATMENT OF GLIOBLASTOMA U-87 BY SYSTEMIC ADMINISTRATION OF AN ANTISENSE PROTEIN-KINASE C-ALPHA PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE, Molecular pharmacology, 50(2), 1996, pp. 236-242
Citation: E. Zylberkatz, MULTIPLE-DRUG INTERACTIONS WITH CYCLOSPORINE IN A HEART-TRANSPLANT PATIENT (VOL 29, PG 127, 1995), The Annals of pharmacotherapy, 29(7-8), 1995, pp. 790-790
Citation: E. Zylberkatz, MULTIPLE-DRUG INTERACTIONS WITH CYCLOSPORINE IN A HEART-TRANSPLANT PATIENT, The Annals of pharmacotherapy, 29(2), 1995, pp. 127-131
Citation: Y. Caraco et al., CAFFEINE PHARMACOKINETICS IN OBESITY AND FOLLOWING SIGNIFICANT WEIGHT-REDUCTION, International journal of obesity, 19(4), 1995, pp. 234-239
Authors:
JUSKO WJ
THOMSON AW
FUNG J
MCMASTER P
WONG SH
ZYLBERKATZ E
CHRISTIANS U
WINKLER M
FITZSIMONS WE
LIEBERMAN R
MCBRIDE J
KOBAYASHI M
WARTY V
SOLDIN SJ
Citation: Wj. Jusko et al., CONSENSUS DOCUMENT - THERAPEUTIC MONITORING OF TACROLIMUS (FK-506), Therapeutic drug monitoring, 17(6), 1995, pp. 606-614
Citation: Y. Caraco et al., ANTIPYRINE DISPOSITION IN OBESITY - EVIDENCE FOR NEGLIGIBLE EFFECT OFOBESITY ON HEPATIC OXIDATIVE-METABOLISM, European Journal of Clinical Pharmacology, 47(6), 1995, pp. 525-530
Authors:
BENCHETRIT E
SCHERRMANN JM
ZYLBERKATZ E
LEVY M
Citation: E. Benchetrit et al., COLCHICINE DISPOSITION IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER WITH PENAL IMPAIRMENT, Journal of rheumatology, 21(4), 1994, pp. 710-713
Citation: D. Pode et al., INTRAVESICAL LIDOCAINE - TOPICAL ANESTHESIA FOR BLADDER MUCOSAL BIOPSIES - REPLY, The Journal of urology, 150(1), 1993, pp. 200-200
Citation: Y. Caraco et al., VALIDITY OF SALIVA SAMPLES FOR THE ESTIMATION OF DIPYRONE METABOLITESPHARMACOKINETICS, Arzneimittel-Forschung, 43-2(11), 1993, pp. 1204-1208